Canaccord raised the firm’s price target on Verona Pharma (VRNA) to $72 from $44 and keeps a Buy rating on the shares. The firm believes the ...

Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for ...

For further information please contact: Verona P Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3 Through October more than 2,200 unique ...

Verona Pharma PLC (NASDAQ:VRNA) shares have reached an all-time high, touching a price level of $62.09. According to ...

Canaccord Genuity maintained a Buy rating on Verona Pharma (NASDAQ:VRNA) while significantly increasing the price target to $72.00 from the previous $44.00. According to InvestingPro data, analyst ...

and now Verona has revealed the drug made approximately $36 million in the final three months of 2024, off more than 16,000 prescriptions. Chief executive David Zaccardelli said Ohtuvayre was off ...

Ohtuvayre is due to launch in the US in the third quarter of this year, assisted by a $650 million debt facility that Verona agreed a few months ago to build its commercial capabilities.

VERONA, Italy :Atalanta thrashed lowly Hellas Verona 5-0 in Serie A on Saturday, with Italian striker Mateo Retegui scoring four times including a hat-trick before the break. Retegui, the league's ...

VERONA, Italy : Mateo Retegui scored four times as Atalanta thrashed lowly Hellas Verona 5-0 in Serie A on Saturday, with the Italy striker completing a hat-trick before the break. Retegui put ...

ROME (AP) — Mateo Retegui scored four goals to lead Atalanta’s 5-0 demolition of Hellas Verona on Saturday, while Santiago Giménez scored in his Serie A debut for AC Milan. Italy striker ...

Sanofi S.A. Part Cert 0.02% €8.03M ...